Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of December 2025
Olivia London @Olivia London
Platinum member since January 2017

Location: United States

Gender: Female

Asset investment style: Hybrid analysis

Market capitalization:

$8,101,696talents

Virtual portfolio value:

$5,230,598talents

Net overall return per annum:

20.20%

AYA current rank order:

#14

Asset investment philosophy:
Olivia London trades U.S. stocks with the top #176 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 21,280 +2,108.33% $161,515
VATE INNOVATE Corp. Common Stock $0.53 $4.14 44,545 +681.13% $160,807
BQ Boqii Holding Limited American Depositary Shares representing Class A Ordinary Shares $0.36 $3.36 47,977 +833.33% $143,931
BQ Boqii Holding Limited Class A Ordinary Shares $0.36 $3.36 47,977 +833.33% $143,931
XBIOW Xenetic Biosciences Inc. Warrants $2.00 $23.16 5,273 +1,058.00% $111,577
LGVN Longeveron Inc. Class A Common Stock $3.45 $26.25 3,044 +660.87% $69,403
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 1,078 +589.24% $44,273
FIVN Five9 Inc. Common Stock $16.31 $110.10 460 +575.05% $43,143
GLOB Globant S.A. Common Shares $34.57 $215.99 217 +524.79% $39,368
HZNP Horizon Therapeutics Public Limited Company Ordinary Shares $16.41 $98.56 458 +500.61% $37,625
Sum $955,573

Top 10 current stock portfolio positions as of December 2025Strategy

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@Andy Yeh Alpha

Blog+More

Sino-American trade talks make positive progress over 3 consecutive days.

Joseph Corr

2019-01-17 10:41:00 Thursday ET

Sino-American trade talks make positive progress over 3 consecutive days.

Sino-American trade talks make positive progress over 3 consecutive days as S&P 500 and global stock market indices post 3-day win streaks. Asian and Eu

+See More

Chicago financial economist Raghuram Rajan views communities as the third pillar of liberal democracy.

Jonah Whanau

2019-02-25 12:41:00 Monday ET

Chicago financial economist Raghuram Rajan views communities as the third pillar of liberal democracy.

Chicago financial economist Raghuram Rajan views communities as the third pillar of liberal democracy in addition to open markets and states. Rajan suggests

+See More

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle

John Fourier

2024-05-05 10:31:00 Sunday ET

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its

+See More

The Economist Intelligence Unit (EIU) continues to track major business risks in light of volatile stock markets.

Fiona Sydney

2019-01-11 10:33:00 Friday ET

The Economist Intelligence Unit (EIU) continues to track major business risks in light of volatile stock markets.

The Economist Intelligence Unit (EIU) continues to track major business risks in light of volatile stock markets, elections, and geopolitics. EIU monitors g

+See More

Santa-Barbara political economy professor Benjamin Cohen proposes new fiscal stimulus to complement the current low-interest-rate monetary policy.

Daphne Basel

2019-08-28 14:46:00 Wednesday ET

Santa-Barbara political economy professor Benjamin Cohen proposes new fiscal stimulus to complement the current low-interest-rate monetary policy.

Santa-Barbara political economy professor Benjamin Cohen proposes new fiscal stimulus to complement the current low-interest-rate monetary policy. Cohen fin

+See More

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma.

Daisy Harvey

2019-06-07 04:02:05 Friday ET

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma.

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic

+See More